YY
Yasuteru Yoshinaga

Well Cited

56
Works
535
Citations
12
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5110152736
  • i10-Index 12
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

Yasuteru Yoshinaga

Also known as: Yasuteru YOSHINAGA, Yasuteru Yoshinaga, Yoshinaga, Yasuteru

56

Total Works

535

Citations

12

H-Index

12

i10-Index

Citation & Works Trend by Year
27 years active
Top Research Topics
Lung Cancer Diagnosis and Treatment (23) Breast Cancer Treatment Studies (16) Breast Lesions and Carcinomas (14) Lung Cancer Research Studies (12) Metastasis and carcinoma case studies (11)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Association of neoadjuvant therapy with locoregional recurrence according to recurrence definitions in breast cancer: a retrospective cohort study World Journal of Surgical Oncology 0
2026 Ipsilateral Breast Tumor Detected 20 Years after Occult Breast Cancer: A Diagnostic Challenge in Distinguishing New Primary Cancer from Late Recurrence Case Reports in Oncology 0
2026 Necrosis of a Metastatic Axillary Lymph Node in Breast Cancer Possibly Induced by Fine-Needle Aspiration Cytology: A Case Report Case Reports in Oncology 0
2026 A Case of Paget’s Disease of the Breast without a Nipple Lesion Surgical Case Reports 0
2024 A case of giant nipple adenoma Surgical Case Reports 5
2021 [Paclitaxel plus Bevacizumab Therapy plus Surgical Resection Results in Local Control of Stage ⅢC Breast Cancer]. PubMed 0
2020 [Comparison of the Incidence of Febrile Neutropenia in Doxorubicin/Cyclophosphamide(AC)and Docetaxel/Cyclophosphamide(TC) Perioperative Chemotherapies for Primary Breast Cancer]. PubMed 1
2017 Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation Endocrinology 89
2016 GLP-1 action attenuates breast cancer growth and progression Diabetes Research and Clinical Practice 1
2015 [Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study]. PubMed 1
2014 Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer Tumor Biology 27
2014 Examination of resection for pulmonary metastases of breast cancer The Journal of the Japanese Association for Chest Surgery 0
2013 Totally Thoracoscopic Surgery and Troubleshooting for Bleeding in Non-Small Cell Lung Cancer The Annals of Thoracic Surgery 52
2012 Image and Pathological Changes after Radiofrequency Ablation of Invasive Breast Cancer: A Pilot Study of Nonsurgical Therapy of Early Breast Cancer World Journal of Surgery 27
2012 Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression Tumor Biology 31

Data source: OpenAlex API